Microglial Phagocytosis and AB-Mediated Neurotoxicity

About the Research Project
Program
Award Type
Standard
Award Amount
$160,326
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
A2000052
Summary
Microglia are specialized phagocytic cells of the central nervous system that engulf or phagocytize material and also mediate inflammatory responses. Based on these properties, they are thought to play a role in AD, especially since cell culture studies have shown that they can also phagocytize Ab. However, there is also some evidence that microglia do not effectively break down internalized Ab. This may lead to chronic activation and contribute to the progression of the disease. Dr. Webster is trying to determine whether the ingestion of Ab by brain cells causes the release of neurotoxic inflammatory molecules called cytokines. The production of oxygen-free radicals is also being monitored, and the production of both cytokines and free radicals will be correlated with the amount of undegraded Ab present inside the microglial cells. This information is important because some of the therapies currently being explored, such as an Ab vaccine, are predicated on the assumption that increased uptake of Ab by microglia will alleviate disease. However, if Ab activates microglia inflammatory responses, then the strategy of stimulating uptake could actually worsen the disease.
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD